Mirae Asset Global ETFs Holdings’s Terns Pharmaceuticals TERN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.37M	Buy	44,956 +5,170	+13%	+$212K	﹤0.01%	1102
2025 Q4	$1.61M	Buy	39,786 +5,810	+17%	+$134K	﹤0.01%	1262
2025 Q3	$255K	Sell	33,976 -5,808	-15%	-$37.1K	﹤0.01%	2196
2025 Q2	$148K	Sell	39,784 -1,794	-4%	-$5.6K	﹤0.01%	2422
2025 Q1	$115K	Buy	41,578 +1,794	+5%	+$7.33K	﹤0.01%	2571
2024 Q4	$220K	Buy	39,784 +8,261	+26%	+$55.9K	﹤0.01%	2351
2024 Q3	$263K	Buy	31,523 +8,745	+38%	+$71.9K	﹤0.01%	2229
2024 Q2	$155K	Buy	+22,778	New	+$138K	﹤0.01%	2376

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TERN Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Terns Pharmaceuticals (TERN) stake by 13% in Q1 2026, buying an estimated $212K and bringing the position to 44,956 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Mirae Asset Global ETFs Holdings first reported a position in TERN in Q2 2024 and has held it in 8 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

Mirae Asset Global ETFs Holdings held 44,956 shares of Terns Pharmaceuticals worth $2.37M as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 5,170 Terns Pharmaceuticals shares in Q1 2026, an estimated $212K.
Terns Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1102 holding.
Mirae Asset Global ETFs Holdings first reported a position in Terns Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.